The Clinical Impact of the Pretreatment Albumin to Fibrinogen Ratio in Esophageal Cancer Patients Who Receive Curative Treatment
View abstract on PubMed
Summary
This summary is machine-generated.The albumin to fibrinogen ratio (AFR) is a significant prognostic marker for esophageal cancer patients undergoing curative resection. Higher AFR levels correlate with improved overall survival and reduced recurrence risk.
Area Of Science
- Oncology
- Biochemistry
Background
- The albumin to fibrinogen ratio (AFR) is an emerging prognostic indicator in various cancers.
- Its role in esophageal cancer prognosis requires further elucidation.
Purpose Of The Study
- To investigate the clinical significance of the albumin to fibrinogen ratio (AFR) as a prognostic marker.
- To evaluate the impact of AFR on survival outcomes in patients with esophageal cancer who underwent curative resection.
Main Methods
- A cohort of 123 esophageal cancer patients treated with curative resection between 2005 and 2020 was analyzed.
- Patients were stratified into high-AFR (≥12.3) and low-AFR (<12.3) groups.
- Prognostic and clinicopathological parameters were compared between groups, with overall survival (OS) analyzed using log-rank tests and Cox regression.
Main Results
- A pretreatment AFR cutoff of 1.23 was identified as significant for OS.
- The high-AFR group demonstrated significantly better 3-year (70.8% vs. 46.6%) and 5-year (59.3% vs. 37.4%) OS rates compared to the low-AFR group.
- AFR was confirmed as a significant independent prognostic factor for OS in both univariate and multivariate analyses, with a trend towards reduced hematological recurrence in the high-AFR group.
Conclusions
- The albumin to fibrinogen ratio (AFR) is a valuable and significant prognostic factor for patients with esophageal cancer.
- Elevated AFR levels are associated with improved survival outcomes after curative resection.

